Denali Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	387.63	205.33	174.96	127.11	218.04	293.48
Short-Term Investments	600.06	662.55	657.37	907.41	1,118	571.93
Cash & Short-Term Investments	987.68	867.88	832.33	1,035	1,336	865.41
Cash Growth	20.76%	4.27%	-19.54%	-22.58%	54.40%	-41.12%
Other Receivables	-	-	-	-	-	1.23
Total Trade Receivables	-	-	-	-	-	1.23
Other Current Assets	35.07	32.78	32.11	29.63	36.1	30.6
Total Current Assets	1,023	900.66	864.44	1,064	1,372	897.23
Net Property, Plant & Equipment	117.27	119.94	125.63	71.64	74.52	69.61
Other Intangible Assets	36	-	-	-	-	-
Long-Term Investments	63.79	98.32	359.37	-	-	425.45
Other Long-Term Assets	26.22	25.94	24.74	18.14	13.4	11.87
Total Assets	1,266	1,145	1,374	1,154	1,460	1,404
Accounts Payable	40.38	3.33	11.14	9.48	2.79	4.78
Accrued Expenses	69.78	95.02	91.07	68.5	66.69	53.17
Unearned Revenue	-	-	-	-	290.05	320.3
Other Current Liabilities	-	-	-	-	4.39	-
Total Current Liabilities	110.16	98.35	102.21	77.98	363.92	378.25
Long-Term Leases	30.19	32.74	42.29	44.98	53.03	58.55
Other Long-Term Liabilities	199.58	-	-	-	0.86	5.07
Total Long-Term Liabilities	229.77	32.74	42.29	44.98	53.89	63.63
Total Liabilities	339.93	131.09	144.5	122.96	417.81	441.87
Common Stock	1.91	1.89	1.77	1.71	1.69	1.55
Additional Paid-in Capital	3,105	3,063	2,765	2,145	2,019	1,608
Accumulated Other Comprehensive Income	-0.68	0.68	2.02	0.64	-6.89	-2.5
Retained Earnings	-2,180	-2,052	-1,539	-1,116	-970.99	-645
Shareholders' Equity	926.1	1,014	1,230	1,031	1,042	962.29
Total Liabilities & Equity	1,266	1,145	1,374	1,154	1,460	1,404
Total Debt	30.19	32.74	42.29	44.98	53.03	58.55
Net Cash (Debt)	957.5	835.14	790.04	989.53	1,283	806.85
Net Cash Growth	14.65%	5.71%	-20.16%	-22.88%	59.04%	-42.59%
Net Cash Per Share	5.42	4.84	4.80	7.20	10.22	6.64
Book Value	926.1	1,014	1,230	1,031	1,042	962.29
Book Value Per Share	5.25	5.87	7.48	7.50	8.30	7.92
Tangible Book Value	890.1	1,014	1,230	1,031	1,042	962.29
Tangible Book Value Per Share	5.04	5.87	7.48	7.50	8.30	7.92

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q